Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 302Carcinoma, Non-Small-Cell Lung 237Prostatic Neoplasms 194Neoplasms 186Lung Neoplasms 145Multiple Myeloma 140Neoplasm Metastasis 107Colorectal Neoplasms 104Melanoma 93Ovarian Neoplasms 88Leukemia, Myeloid, Acute 80Pancreatic Neoplasms 77Lymphoma 73Leukemia, Lymphocytic, Chronic, B-Cell 69Brain Neoplasms 67Carcinoma, Renal Cell 66Lymphoma, Non-Hodgkin 64Squamous Cell Carcinoma of Head and Neck 62Carcinoma, Hepatocellular 59Urinary Bladder Neoplasms 58Hematologic Neoplasms 57Recurrence 56Head and Neck Neoplasms 56Triple Negative Breast Neoplasms 55Glioblastoma 52Endometrial Neoplasms 51Lymphoma, Follicular 50Uterine Cervical Neoplasms 49Sarcoma 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 46

Interventions

sofosbuvir-velpatasvir drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Hepatitis C, Chronic × 90 days × Clear all
NCT03520660 2026-06-03

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

National Institutes of Health Clinical Center (CC)

Phase 4 Active not recruiting
121 enrolled
Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡